Antibody-containing formulation
In a non-limiting embodiment, the present disclosure pertains to an antibody-containing formulation containing an anti-IL-6 receptor antibody as an active ingredient, the formulation containing a histidine-aspartate buffer or a histidine-glutamate buffer, Poloxamer 188, and arginine and having a pH...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!